Search results
Skill Checkup: A Man With Treated PsA and Abdominal Pain
Medscape· 3 days agoA 48-year-old Asian man in the United States presents with fatigue, weakness, and a dull pain in his...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 2 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 1 day agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 2 days agoThe studies also achieved a key secondary endpoint of endoscopic improvement. Skyrizi is already...
Walking Helps Guard Against Recurrent Low Back Pain
Medscape· 1 day agoRegular walking can help prevent recurrent episodes of low back pain, a new study suggests. Among adults who recently recovered from an episode of low...
Johnson & Johnson (NYSE:JNJ) Position Boosted by PVG Asset Management Corp
ETF DAILY NEWS· 4 days agoPVG Asset Management Corp lifted its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 28.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional ...
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 3 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
A New Psychotherapeutic 'Gold Standard' for Chronic Pain?
Medscape· 2 days agoA single course of treatment with emotional awareness and expression therapy (EAET) was associated...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 6 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 4 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...